Evidence map›Paper›PMID 42728863›Full record

ArticleSkin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)2026

Combined Effect of Silybin and Sodium Acetylated Hyaluronate on UV-Induced Photoaging.

Sen Hou, Hanliang Song, Jianying Zhang, Anzhang Li

Abstract read
In one paragraph

Article in Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sen HouGuyu Biotechnology Group Co., Ltd, Guangzhou, Guangdong, China.ORCID https://orcid.org/0000-0002-6871-4419
Hanliang SongGuyu Biotechnology Group Co., Ltd, Guangzhou, Guangdong, China.
Jianying ZhangGuangzhou Zhongkejian Technology Testing Co., Ltd, Guangzhou, Guangdong, China.
Anzhang LiGuyu Biotechnology Group Co., Ltd, Guangzhou, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExposure to solar ultraviolet (UV) radiation is a major cause of skin photoaging, which is characterized by decreased collagen levels in the dermis. Both silybin and sodium acetylated hyaluronate (HA) are potential anti-aging compounds. However, when used alone, both agents show limited anti-aging efficacy. This study aimed to examine the combined effects of silybin and HA on UV-induced skin photoaging and elucidate the underlying mechanisms.

methodsIn this study, cytotoxicities of silybin and HA were assessed across a range of concentrations, both with and without UV exposure. We quantified mRNA levels of matrix metalloproteinase-1 (MMP-1), collagen type I (Col I), and collagen type III (Col III) after silybin and HA treatment to study their collagen synthesis promotion and degradation inhibition effects. Reducibility and reactive oxygen species (ROS) scavenging activity were also characterized for each compound. Collagen protein content was then measured after individual and combined treatments.

resultsSilybin showed obvious cytotoxicity when its concentration reached 0.01%, while HA remained largely non-toxic even at concentrations of 1%. UV irradiation slightly increased the cytotoxicity of both silybin and HA. Notably, silybin effectively inhibited collagen degradation by downregulating MMP-1 mRNA expression, although it failed to upregulate Col I and III mRNA levels. In contrast, HA did not inhibit, and at higher concentrations slightly elevated, MMP-1 mRNA expression, while it was efficient in promoting Col I and III mRNA expression. Therefore, combined treatment with silybin and HA led to the downregulation of MMP-1 mRNA levels and upregulation of Col I and III mRNA levels. Silybin also showed high reducibility and therefore provided strong ROS scavenging capacity. As MMP-1 synthesis is primarily induced by ROS, silybin exhibited strong MMP-1 inhibition. Meanwhile, HA showed weak ROS scavenging capacity owing to its low reducibility. Nevertheless, the combination of silybin and HA inhibited collagen degradation (primarily via silybin) and promoted Col I and III mRNA expression and protein synthesis (primarily via HA), thereby increasing overall collagen protein levels.

conclusionsThis study reveals the complementary mechanisms through which silybin and HA collectively increase dermal collagen levels-silybin by protecting existing collagen from degradation and HA by promoting collagen synthesis-guiding their combined use in cosmetics to protect the skin from UV-induced photoaging.

Indexed as

Hyaluronic AcidSilymarinSkin AgingUltraviolet RaysAntioxidantsCollagen Type ICollagen Type IIIHumansMatrix Metalloproteinase 1Reactive Oxygen SpeciesSilybinAntioxidantsCollagen Type ICollagen Type IIIHyaluronic AcidMatrix Metalloproteinase 1MMP1 protein, humanReactive Oxygen SpeciesSilybinSilymarincollagenphotoagingROSsilybinsodium acetylated hyaluronate

Identifiers

PMID42728863
PMCPMC13570327

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.